Numab Innovation AG - Company Review
Numab Innovation AG - Company ReviewSummary
Numab Innovation AG (Numab) designs and develops novel therapeutics for the treatment of severe diseases. The company’s lead program ND007, a bispecific antibody fragment which is being evaluated for the treatment of autoimmune diseases. Numab’s other pipeline drug candidates include ND009, ND016, ND017 and other multiple programs are being development to treat inflammatory bowel disease, autoimmune disorders and metabolic disorders. It developed a proprietary antibody discovery and engineering technology to produce antibody Fv fragments. The company provides its discovery engine in partnership with other organizations such as Intarcia Therapeutics, Inc and Tillotts Pharma AG to develop novel therapies. Numab is headquartered in Wadenswil, Zurich, Switzerland.
This comprehensive company report of Numab Innovation AG provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.